Loading
BT
bioMmune Technologies Inc. Stock: price and insider trades · Canada
bioMmune Technologies Inc.: what insiders have been doing
bioMmune Technologies Inc. is a listed company. Its directors and officers file their transactions with SEDI. No insider at bioMmune Technologies Inc. has published a filing in the past twelve months. The most recent one dates from 22 April 2016.
The full history, which starts in 2013, counts 5 purchases against no sales.
Source: insider filings from SEDI. Past trades are no guide to future returns.
Insider Decl.
6
Thresholds
n/a
Buy Volume
n/a
5 ops. · all time
Sell Volume
n/a
n/a
Last declaration on 22 April 2016
Declarations6 total
23,333 sharesCommon SharesTSXSEDI:2828992
Canonical exit: 21 Jul 2016 (T+90)
4,000 sharesCommon SharesTSXSEDI:2788196
Canonical exit: 12 May 2016 (T+90)
10,000 sharesCommon SharesTSXSEDI:2783490
Canonical exit: 2 May 2016 (T+90)
5,000 sharesCommon SharesTSXSEDI:2780368
Canonical exit: 26 Apr 2016 (T+90)
10,000 sharesCommon SharesTSXSEDI:2778048
Canonical exit: 21 Apr 2016 (T+90)
Common SharesTSXSEDI:2285848
6 of 6 declarations
About bioMmune Technologies Inc.
bioMmune Technologies Inc. is a company focused on developing biopharmaceutical solutions. It is listed on the XTSE market.
